Back to article
lifebiosciences.com

Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies (opens in new tab)

Covered by 5 sources See all sources covering this story including Refractor, MIT Technology ReviewDiscussed on Hacker News

Covered in 5 articles

Refractor·

Anti-aging gene therapy makes old cells young again in landmark human trial

Feeds
MIT Technology Review·

Why “reprogramming” is the buzziest approach to reversing aging right now

Discussed on Hacker News
Feeds

In other languages

MITテクノロジーレビュー·

巨額が集まる若返り技術「リプログラミング」、今度こそ本物か

Feeds
lesnumeriques.com·

Rajeunir des cellules humaines : le tout premier essai clinique au monde vient de commencer, les espoirs sont immenses

Feeds
最新情報 Feed·

加齢に伴う視力低下の回復を目指す薬剤をヒトに初投与──長寿スタートアップが発表

Feeds

Keyboard Shortcuts

Navigation

Next / previous post
j/k
Open post
oorEnter
Preview post
v

Post Actions

Love post
a
Like post
l
Dislike post
d
Undo reaction
u
Save / unsave
s

Recommendations

Add interest / feed
Enter
Not interested
x

Go to

Home
gh
Interests
gi
Feeds
gf
Likes
gl
History
gy
Changelog
gc
Settings
gs
Discover
gb
Search
/

General

Show this help
?
Submit feedback
!
Close modal / unfocus
Esc

Press ? anytime to show this help